Graham Heery
About Graham Heery
Graham Heery is an Associate Director of Nonclinical and CMC at Starpharma, with extensive experience in drug development and a strong background in bioanalytical and analytical science. He has held various managerial roles at Starpharma and previously worked at YM Biosciences Australia, and he holds degrees in Drug Development and Analytical Chemistry.
Current Role at Starpharma
Graham Heery currently serves as the Associate Director of Nonclinical and CMC at Starpharma, a position he has held since 2022. In this role, he focuses on overseeing nonclinical development and chemistry, manufacturing, and controls (CMC) processes. His work is based in the Greater Melbourne Area, where he applies his extensive experience in drug development to guide projects and ensure compliance with industry standards.
Previous Positions at Starpharma
Graham Heery has held multiple roles at Starpharma, contributing significantly to the organization’s drug development efforts. He worked as the Development Projects Manager for nine months in 2014, followed by a three-year tenure as CMC and Non-Clinical Development Manager from 2015 to 2018. He then served as Senior Nonclinical and CMC Development Manager from 2018 to 2022, accumulating a total of over seven years of experience at the company.
Education and Expertise
Graham Heery obtained a Master of Medical Science in Drug Development from the University of New South Wales (UNSW) from 2004 to 2008. He also holds a Bachelor of Applied Science in Chemistry and Analytical Chemistry from Queensland University of Technology (QUT), which he completed from 1991 to 1997. His educational background supports his strong expertise in bioanalytical and analytical science, as well as his specialized skills in Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards.
Experience in Drug Development
Before joining Starpharma, Graham Heery worked as a Drug Development Project Manager at YM Biosciences Australia for five months in 2010. He also served as Bioanalytical Services Manager at Starpharma from 2002 to 2007, where he developed foundational skills in drug development processes. His experience includes conducting both internal and external audits within the pharmaceutical industry, enhancing his understanding of regulatory compliance and quality assurance.